PURPOSE: To evaluate the safety and efficacy of Gold Micro Shunt (GMS) implantation to the supraciliary space in patients with glaucoma. METHODS: A total of 38 patients with glaucoma with uncontrolled intraocular pressure (IOP) underwent implantation of the GMS in this prospective 2-center study. MAIN OUTCOME MEASURES: Intraocular pressure and surgical complications. RESULTS: A total of 38 patients with glaucoma participated. The mean follow-up time was 11.7 months. The IOP decreased a mean (SD) of 9 mm Hg from 27.6 (4.7) to 18.2 (4.6) mm Hg (P < .001). Surgical success was achieved in 30 patients (79%) (IOP >5 and <22 mm Hg, with or without antiglaucoma medication). Eight patients had mild to moderate transient hyphema. CONCLUSIONS: Implantation of GMS to the supraciliary space is a safe and effective method of controlling IOP in patients with glaucoma. Use of the GMS resulted in a significant decrease in IOP. APPLICATION TO CLINICAL PRACTICE: The GMS could be an alternative surgical device to standard trabeculectomy.
PURPOSE: To evaluate the safety and efficacy of Gold Micro Shunt (GMS) implantation to the supraciliary space in patients with glaucoma. METHODS: A total of 38 patients with glaucoma with uncontrolled intraocular pressure (IOP) underwent implantation of the GMS in this prospective 2-center study. MAIN OUTCOME MEASURES: Intraocular pressure and surgical complications. RESULTS: A total of 38 patients with glaucoma participated. The mean follow-up time was 11.7 months. The IOP decreased a mean (SD) of 9 mm Hg from 27.6 (4.7) to 18.2 (4.6) mm Hg (P < .001). Surgical success was achieved in 30 patients (79%) (IOP >5 and <22 mm Hg, with or without antiglaucoma medication). Eight patients had mild to moderate transient hyphema. CONCLUSIONS: Implantation of GMS to the supraciliary space is a safe and effective method of controlling IOP in patients with glaucoma. Use of the GMS resulted in a significant decrease in IOP. APPLICATION TO CLINICAL PRACTICE: The GMS could be an alternative surgical device to standard trabeculectomy.
Authors: R Allemann; O Stachs; K Falke; W Schmidt; S Siewert; K Sternberg; B Chichkov; A Wree; K-P Schmitz; R F Guthoff Journal: Ophthalmologe Date: 2013-08 Impact factor: 1.059
Authors: Larry Kagemann; Bo Wang; Gadi Wollstein; Hiroshi Ishikawa; Jessica E Nevins; Zach Nadler; Ian A Sigal; Richard A Bilonick; Joel S Schuman Journal: Invest Ophthalmol Vis Sci Date: 2014-03-25 Impact factor: 4.799
Authors: Steven J Gedde; Joyce C Schiffman; William J Feuer; Leon W Herndon; James D Brandt; Donald L Budenz Journal: Am J Ophthalmol Date: 2012-01-15 Impact factor: 5.258